Jay Shepard
Directeur/Bestuurslid bij ESPERION THERAPEUTICS, INC.
Vermogen: 1 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Jay Shepard
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Santa Clara University
126
| College/University | Other Consumer Services | 126 |
| Public Company | Pharmaceuticals: Major | 30 | |
| Public Company | Pharmaceuticals: Major | 29 | |
| Public Company | Pharmaceuticals: Major | 27 | |
Craig Hospital
 Craig Hospital Hospital/Nursing ManagementHealth Services Craig Hospital is a center for specialty rehabilitation and research for people with spinal cord injury and traumatic brain injury. The firm provides a system of inpatient and outpatient medical care, rehabilitation, neurosurgical rehabilitative care and long-term follow up services. The company was founded in 1907 and is headquartered in Denver, CO.
22
| Non-Profit Organization | Hospital/Nursing Management | 22 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.
21
| Private Company | Investment Managers | 21 |
| Public Company | Biotechnology | 14 | |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands.
12
| Private Company | Investment Managers | 12 |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
| Subsidiary | Pharmaceuticals: Major | 7 | |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Altamont Pharma Acquisition Corp.
 Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX.
5
| Private Company | Financial Conglomerates | 5 |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA.
3
| Holding Company | Biotechnology | 3 |
Cessation Therapeutics, LLC
 Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jay Shepard via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
3com Corp. (Massachusetts)
 3com Corp. (Massachusetts) Information Technology ServicesTechnology Services 3com Megahertz Corp. provides voice and data networking products and services. The company was founded by Robert M. Metcalfe, Howard S. Charney and John P. Marshall in 1979 and is headquartered in Marlborough, MA. | Information Technology Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ADOBE INC. | Packaged Software | Director of Finance/CFO Human Resources Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
| APPLIED MATERIALS, INC. | Industrial Machinery | Director of Finance/CFO Chairman | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | President President | |
| HP INC. | Computer Processing Hardware | Corporate Officer/Principal Human Resources Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| VIVUS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chairman Chairman Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| INFOBLOX INC | Information Technology Services | Human Resources Officer | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Public Communications Contact | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal | |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| Dalhousie University | College/University | Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Graduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree Graduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Doctorate Degree Undergraduate Degree | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member Director/Board Member | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Chairman Masters Business Admin | |
| The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Leavey School of Business | College/University | Corporate Officer/Principal Masters Business Admin | |
Meryx, Inc.
 Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member President | |
| JIYA ACQUISITION CORP. | Financial Conglomerates | Chairman Chief Executive Officer | |
| MINERALYS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
Kirilys Therapeutics, Inc.
 Kirilys Therapeutics, Inc. Medical/Nursing ServicesHealth Services Kirilys Therapeutics, Inc. is an American preclinical-stage biopharmaceutical company that focuses on developing multiple precision oncology assets. The company is based in California and is committed to advancing the field of oncology. The company's initial asset is KRLS-017, a novel CDK7 inhibitor that has the potential to improve the treatment of multiple cancers. Kirilys Therapeutics was founded by Takeshi Takahashi, Brian Taylor Slingsby, and Kapil Dhingra, with Brian Taylor Slingsby serving as the CEO since incorporation. | Medical/Nursing Services | Chief Operating Officer Chief Executive Officer | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Mauritius (Eiland) | 2 |
| Zwitserland | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 16 |
| Technology Services | 5 |
| Commercial Services | 3 |
| Finance | 3 |
Operationeel
| Director/Board Member | 475 |
| Corporate Officer/Principal | 171 |
| Independent Dir/Board Member | 139 |
| Chairman | 79 |
| Chief Executive Officer | 61 |
Sterkste connecties
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| Fred Eshelman | 34 |
| Catherine Moukheibir | 29 |
| Nicole Vitullo | 28 |
| Robert Finocchio | 27 |
| Julie McHugh | 26 |
| Alexander Denner | 25 |
| Peter Gotcher | 24 |
| Antonio Gotto | 23 |
| Joseph Bronson | 22 |
| Wim Roelandts | 20 |
| Lota Zoth | 20 |
| Stephen Rocamboli | 20 |
| Wendy Yarno | 19 |
| Andrew Dreyfus | 19 |
- Beurs
- Insiders
- Jay Shepard
- Bedrijfsconnecties
